Steve Tutewohl - Mar 1, 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role: Chief Operating Officer
Signature: /s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol: EVH
Transactions as of: Mar 1, 2022
Transactions value $: -$185,816
Form type: 4
Date filed: 3/3/2022, 08:15 PM
Previous filing: Feb 7, 2022
Next filing: Mar 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVH	Class A Common Stock	Award	$0	+20K	+20.23%	$0.00	119K	Mar 1, 2022	Direct	F1, F2, F3
transaction	EVH	Class A Common Stock	Tax liability	-$110K	-4.01K	-3.37%	$27.40	115K	Mar 1, 2022	Direct	F3, F4
transaction	EVH	Class A Common Stock	Options Exercise	$71.6K	+5.39K	+4.66%	$13.29	121K	Mar 1, 2022	Direct	F3, F5
transaction	EVH	Class A Common Stock	Sale	-$148K	-5.39K	-4.48%	$27.41	115K	Mar 1, 2022	Direct	F3, F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVH	Class A Common Stock Option (right to buy)	Options Exercise	$0	-5.39K	-50%	$0.00	5.39K	Mar 1, 2022	Class A Common Stock	5.39K	$13.29	Direct	F5, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2	Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025.
F3	Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4	This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
F5	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021.
F6	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $28.02, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7	The Class A Common Stock Options exercised vested on March 1, 2022.